Penta Pharma Egypt is a leading generic pharmaceutical joint stock company based in Egypt, with a strong focus on providing high-quality and affordable medications. Their extensive generics portfolio, approved by the Egyptian Drug Authority (EDA), covers a diverse range of therapeutic areas. The company's state-of-the-art manufacturing facility in Ismailia's Abu Sultan industrial zone is a testament to their commitment to quality, specializing in solid and semi-solid preparations while adhering to the highest international standards. The site has received positive audits from the Ministry of Health and Population in Egypt and other countries in Africa and the Middle East, along with an ISO 9001 certification. With a patient-centric approach, Penta Pharma Egypt prioritizes the need for safe and quality medications, making them accessible to individuals across Egypt and beyond. Their dedication to manufacturing and marketing the most updated portfolio of EDA-approved generic products showcases their commitment to providing innovative and effective medications. As a company, they aim to be more than a pharmaceutical entity, positioning themselves as your healthcare partner, dedicated to contributing to the well-being of individuals. Overall, Penta Pharma Egypt's focus on quality, commitment to innovation, and patient-centric approach make them a significant player in the pharmaceutical industry, not only in Egypt but also in the wider region of Africa and the Middle East.
There is no investment information
No recent news or press coverage available for Penta Pharma Egypt.